Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. [electronic resource]
Producer: 20120103Description: 2560-7 p. digitalISSN:- 1879-0852
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Body Mass Index
- Camptothecin -- administration & dosage
- Capecitabine
- Chemotherapy, Adjuvant -- methods
- Colorectal Neoplasms -- drug therapy
- Deoxycytidine -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Irinotecan
- Male
- Middle Aged
- Molecular Targeted Therapy
- Obesity -- complications
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Retrospective Studies
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.